{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:10:58Z","timestamp":1763017858828,"version":"3.37.3"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T00:00:00Z","timestamp":1522886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Development and Education Unit, Region J\u00e4mtland H\u00e4rjedalen"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195324","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T21:18:10Z","timestamp":1522963090000},"page":"e0195324","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serious hemorrhages after ischemic stroke or TIA \u2013 Incidence, mortality, and predictors"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-7966","authenticated-orcid":true,"given":"Joachim","family":"\u00d6gren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lotta","family":"Irewall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"S\u00f6derstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mooe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,5]]},"reference":[{"key":"ref1","first-page":"588","article-title":"Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients","volume":"74","author":"W HR Feng","year":"2010"},{"key":"ref2","first-page":"1489","article-title":"Risk and cumulative risk of stroke recurrence: A systematic review and meta-analysis","volume":"42","author":"KM WC Mohan","year":"2011"},{"key":"ref3","first-page":"2098","article-title":"Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: A cohort study","volume":"365","author":"I KL van Wijk","year":"2005"},{"key":"ref4","first-page":"CD000187","article-title":"Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack","author":"R KP Saxena","year":"2004"},{"key":"ref5","first-page":"1849","article-title":"Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"C BL Baigent","year":"2009"},{"key":"ref6","first-page":"CD001342","article-title":"Vitamin k antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin","author":"EL AA De Schryver","year":"2012"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1474-4422(10)70038-7","article-title":"Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events","volume":"9","author":"GJ Hankey","year":"2010","journal-title":"The Lancet. Neurology"},{"key":"ref8","first-page":"315","article-title":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of rocket af","volume":"11","author":"GJ PM Hankey","year":"2012"},{"key":"ref9","first-page":"503","article-title":"Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the aristotle trial","volume":"11","author":"JD LR Easton","year":"2012"},{"key":"ref10","first-page":"1157","article-title":"Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: A subgroup analysis of the re-ly trial","volume":"9","author":"HC CS Diener","year":"2010"},{"key":"ref11","first-page":"1305","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"MI Chimowitz","year":"2005"},{"key":"ref12","first-page":"1255","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke","volume":"342","year":"1993","journal-title":"Eaft."},{"key":"ref13","first-page":"115","article-title":"Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (esprit): A randomised controlled trial","volume":"6","author":"PH Halkes","year":"2007"},{"key":"ref14","first-page":"1444","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"JP Mohr","year":"2001"},{"key":"ref15","first-page":"817","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"RG Hart","year":"2012"},{"key":"ref16","first-page":"1107","article-title":"Combination antiplatelet therapy for secondary stroke prevention: Enhanced efficacy or double trouble?","volume":"103","author":"MH Usman","year":"2009"},{"key":"ref17","first-page":"14","article-title":"Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study","volume":"130","author":"GW BRJ Petty","year":"1999"},{"key":"ref18","first-page":"2106","article-title":"Secondary stroke prevention in atrial fibrillation: Lessons from clinical practice","volume":"31","author":"A PI Evans","year":"2000"},{"key":"ref19","first-page":"1488","article-title":"The warfarin-aspirin symptomatic intracranial disease study","volume":"45","author":"MI Chimowitz","year":"1995"},{"key":"ref20","first-page":"80","article-title":"Hemorrhage after ischemic stroke-relation to age and previous hemorrhage in a nationwide cohort of 58 868 patients","volume":"8","author":"S HK Asberg","year":"2013"},{"key":"ref21","first-page":"423","article-title":"Functional outcome 3 months after stroke predicts long-term survival","volume":"25","author":"M NB Eriksson","year":"2008"},{"key":"ref22","first-page":"28","article-title":"Implementation of telephone-based secondary preventive intervention after stroke and transient ischemic attack\u2014participation rate, reasons for nonparticipation and one-year mortality","volume":"4","author":"AL Irewall","year":"2014"},{"key":"ref23","first-page":"673","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The gusto investigators","volume":"329","year":"1993"},{"key":"ref24","first-page":"142","article-title":"Thrombolysis in myocardial infarction (timi) trial, phase i: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"JH Chesebro","year":"1987"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"S Schulman","year":"2005","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/CIRCOUTCOMES.114.001606","article-title":"Intracranial hemorrhage after ischemic stroke: Incidence, time trends, and predictors in a swedish nationwide cohort of 196 765 patients","volume":"8","author":"J IA \u00d6gren","year":"2015","journal-title":"Circulation. Cardiovascular quality and outcomes"},{"key":"ref27","first-page":"2575","article-title":"Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: Results from the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (charisma) trial","volume":"121","author":"PB Berger","year":"2010"},{"key":"ref28","first-page":"1240","article-title":"Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the cast and ist collaborative groups","volume":"31","author":"ZM Chen","year":"2000"},{"key":"ref29","first-page":"490","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: A population-based cohort study","volume":"390","author":"L Li","year":"2017"},{"key":"ref30","first-page":"2298","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: A report from the swedish atrial fibrillation cohort study","volume":"125","author":"L RM Friberg","year":"2012"},{"key":"ref31","first-page":"453","article-title":"Lipid management in the prevention of stroke: Review and updated meta-analysis of statins for stroke prevention","volume":"8","author":"P Amarenco","year":"2009"},{"key":"ref32","first-page":"757","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions","volume":"363","author":"R Collins","year":"2004"},{"key":"ref33","first-page":"413","article-title":"Intracranial hemorrhage after ischemic stroke: Incidence, time trends, and predictors in a swedish nationwide cohort of 196 765 patients","volume":"8","author":"J Ogren","year":"2015"},{"key":"ref34","first-page":"460","article-title":"Do statins protect against upper gastrointestinal bleeding?","volume":"67","author":"SE Gulmez","year":"2009"},{"key":"ref35","first-page":"369 e369","article-title":"Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?","volume":"120","author":"JD Douketis","year":"2007"},{"key":"ref36","first-page":"849","article-title":"Statin therapy and gastrointestinal hemorrhage: A retrospective cohort study with propensity score-matching","volume":"24","author":"R Badillo","year":"2015"},{"key":"ref37","first-page":"976 e971","article-title":"Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: Analysis of the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 (opus-timi 16) trial","volume":"151","author":"S Atar","year":"2006"},{"key":"ref38","unstructured":"Riks-Stroke-Collaboration. Riks-stroke website (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.riks-stroke.org\/\" xlink:type=\"simple\">http:\/\/www.riks-stroke.org\/<\/ext-link>). 2011;2014"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T20:56:21Z","timestamp":1540241781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195324"}},"subtitle":[],"editor":[{"given":"Stephan","family":"Meckel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,5]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195324","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,4,5]]}}}